Wendy Carruthers Boston Scientific Corp (BSX) insider trading activity

Wendy Carruthers is EVP, Human Resources of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 29,308 shares of BSX, which is worth approximately $2.95 Million. The most recent transaction as insider was on Feb 17, 2024, when has been sold 998 shares (Common Stock) at a price of $65.82 per share, resulting in proceeds of $65,688. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.3K

0% 3M change

45.51% 12M change

Total Value Held $2.95 Million

Wendy Carruthers Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 17 2024	SELL Payment of exercise price or tax liability	$65,688 $65.82 p/Share	998 Reduced 1.6%	61,247 Common Stock
Feb 17 2024	BUY Exercise of conversion of derivative security	-	2,250 Added 3.49%	62,245 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$59,896 $65.82 p/Share	910 Reduced 1.49%	59,995 Common Stock
Feb 16 2024	BUY Exercise of conversion of derivative security	-	2,051 Added 3.26%	60,905 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$61,927 $65.95 p/Share	939 Reduced 1.57%	58,854 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	-	2,115 Added 3.42%	59,793 Common Stock
Feb 06 2024	SELL Payment of exercise price or tax liability	-	7,983 Reduced 12.16%	57,678 Common Stock
Feb 06 2024	BUY Grant, award, or other acquisition	-	18,000 Added 21.52%	65,661 Common Stock
Jan 01 2024	SELL Payment of exercise price or tax liability	$311,017 $57.81 p/Share	5,380 Reduced 10.14%	47,661 Common Stock
Jan 01 2024	BUY Exercise of conversion of derivative security	-	11,772 Added 18.16%	53,041 Common Stock
Dec 15 2023	SELL Open market or private sale	$649,079 $55.61 p/Share	11,672 Reduced 22.05%	41,269 Common Stock
Dec 15 2023	BUY Exercise of conversion of derivative security	$94,212 $14.7 p/Share	6,409 Added 10.8%	52,941 Common Stock
Nov 15 2023	SELL Open market or private sale	$632,218 $54.17 p/Share	11,671 Reduced 20.05%	46,532 Common Stock
Nov 15 2023	BUY Exercise of conversion of derivative security	$94,197 $14.7 p/Share	6,408 Added 9.92%	58,203 Common Stock
Oct 16 2023	SELL Open market or private sale	$581,099 $49.79 p/Share	11,671 Reduced 18.39%	51,795 Common Stock
Oct 16 2023	BUY Exercise of conversion of derivative security	$94,197 $14.7 p/Share	6,408 Added 9.17%	63,466 Common Stock
Sep 15 2023	SELL Open market or private sale	$629,650 $53.95 p/Share	11,671 Reduced 16.98%	57,058 Common Stock
Sep 15 2023	BUY Exercise of conversion of derivative security	$94,197 $14.7 p/Share	6,408 Added 8.53%	68,729 Common Stock
Aug 15 2023	SELL Open market or private sale	$598,722 $51.3 p/Share	11,671 Reduced 15.77%	62,321 Common Stock
Aug 15 2023	BUY Exercise of conversion of derivative security	$94,197 $14.7 p/Share	6,408 Added 7.97%	73,992 Common Stock
Jul 17 2023	SELL Open market or private sale	$616,812 $52.85 p/Share	11,671 Reduced 14.73%	67,584 Common Stock
Jul 17 2023	BUY Exercise of conversion of derivative security	$94,197 $14.7 p/Share	6,408 Added 7.48%	79,255 Common Stock
Jun 15 2023	SELL Open market or private sale	$621,364 $53.24 p/Share	11,671 Reduced 13.81%	72,847 Common Stock
Jun 15 2023	BUY Exercise of conversion of derivative security	$94,197 $14.7 p/Share	6,408 Added 7.05%	84,518 Common Stock
May 15 2023	SELL Open market or private sale	$624,281 $53.49 p/Share	11,671 Reduced 13.0%	78,110 Common Stock

Also insider at

NVST

Envista Holdings Corp Healthcare

Director